Ondansetron hydrochloride 8 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
Added on Wednesday, April 01, 1998
Terminated on Saturday, December 31, 2011: do not use.
Status changed on Sunday, January 01, 2012 to: No maintenance for this code
BETOS Classification: Chemotherapy
Medicare coverage status: Special coverage instructions apply
2014 HCPCS Q0179
